Skip to Main Content

Paper Details

Pharmacological and Toxicological Properties of the Potent Oral <i>γ</i>-Secretase Modulator BPN-15606.
J Pharmacol Exp Ther
31
2017
-secretase, A neuritic plaque, A37, A38, A40 peptide, A42, A42 peptide, AD, APP, Alzheimer's disease, BPN-15606, Notch, Secretase, amino-, as, carboxyl, carboxyl-terminal fragments, human, human neural cell culture model, hyperphosporylated tau, mice, mouse, neural, neurofibrillary, neurofibrillary tangles, pThr181 tau, rats, t-secretase
Author NameAffiliation
Steven L WagnerUniversity of California, R.A.R.) Integrated Nonclinical Development Solutions, Pennsylvania (J.H.L.) and Genetics and Aging Research Unit, Massachusetts General Hospital
Kevin D RynearsonUniversity of California, R.A.R.) Integrated Nonclinical Development Solutions, Pennsylvania (J.H.L.) and Genetics and Aging Research Unit, Massachusetts General Hospital
Can ZhangUniversity of California, R.A.R.) Integrated Nonclinical Development Solutions, Pennsylvania (J.H.L.) and Genetics and Aging Research Unit, Massachusetts General Hospital
Phuong NguyenUniversity of California, R.A.R.) Integrated Nonclinical Development Solutions, Pennsylvania (J.H.L.) and Genetics and Aging Research Unit, Massachusetts General Hospital
Phuong NguyenUniversity of California, R.A.R.) Integrated Nonclinical Development Solutions, Pennsylvania (J.H.L.) and Genetics and Aging Research Unit, Massachusetts General Hospital
William C MobleyUniversity of California, R.A.R.) Integrated Nonclinical Development Solutions, Pennsylvania (J.H.L.) and Genetics and Aging Research Unit, Massachusetts General Hospital
Rudolph E TanziUniversity of California, R.A.R.) Integrated Nonclinical Development Solutions, Pennsylvania (J.H.L.) and Genetics and Aging Research Unit, Massachusetts General Hospital
  • 1 - 7

Datasets